Entity/Public Space Stock Epinephrine

Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.

Thirty-two states have now passed what are called “entity laws” (as of October 4, 2018), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.

States colored red are without entity legislation.

Click on the state listings below to read the legislation.

 

 Green states:  Red states:
Alaska Connecticut
Alabama Delaware
Arkansas District of Columbia
Arizona Hawaii
California Kansas
Colorado Louisiana
Florida Maryland
Georgia Massachusetts
Idaho Mississippi
Illinois  Montana
Indiana Nebraska
Iowa New Mexico
Kentucky North Dakota
Michigan Pennsylvania
Minnesota  South Dakota
Missouri Texas
Maine Vermont
Nevada  Virginia
New Hampshire  Wyoming
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Rhode Island
South Carolina
Tennessee
Utah
Washington
West Virginia
Wisconsin

For questions and to get involved in Entity Legislation in your state, contact Charmayne Anderson at canderson@allergyasthmanetwork.org or 800.878.4403.